Systemic absorption of sunscreen after topical application [4]

Lancet

Volumn 350, Issue 9081, 1997, Pages 863-864

  Hayden, Cameron G J ^b   Roberts, Michael S ^b   Benson, Heather A E ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

OXYBENZONE; SUNSCREEN;

DRUG ABSORPTION; DRUG URINE LEVEL; EPIDERMIS; HUMAN; HUMAN EXPERIMENT; LETTER; NORMAL HUMAN; PRIORITY JOURNAL; SKIN CANCER; SUN EXPOSURE; SUNBURN; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET RADIATION;

EID: 0030870411     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62032-6     Document Type: Article

References (5)

1. USA Food and Drug Administration. Sunscreen drug products for over the counter human use: tentative final monograph. Fed Reg 1993; 58: 28194-302.
2. Cosmetic Ingredient Review. Final report on the safety of benzophenone-1, -3, -4, -5, -9, and -11. J Am Coll Toxicol 1983; 2: 35-77.
3. Jiang R, Hayden CGJ, Prankerd RP, Robers MS, Benson HAE. High performance liquid chromatographic assay for common sunscreening agents in cosmetic products, bovine serum albumin solution and human plasma. J Chromatogr B 1996; 682: 137-45.
4. Treffel P, Gabard B. Skin penetration and sun protection factor of ultra-violet filters from two vehicles. Pharm Res 1996; 13: 770-74.
5. Okereke CS, Abdel-Rhaman MS, Friedman MA. Disposition of benzophenone-3 after dermal administration in male rats. Toxicol Lett 1994; 73: 113-22.